文献速递血栓与止血

一项前瞻性盲法研究:PF4依赖性试验用于HIT诊断

A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.
PubMed 文献 · Blood · 2021-01-01

该前瞻性盲法研究纳入409例疑似肝素诱导的血小板减少症(HIT)连续成人患者,按预设标准(结合4Ts评分与HIT ELISA结果)分为疾病阳性、阴性或不确定。比较PF4依赖性P选择素表达试验(PEA)与金标准14C-血清素释放试验(SRA)的诊断准确性,PEA的曲线下面积(AUC)为0.94(95%CI 0.87-1.0),与SRA的0.91(95%CI 0.82-1.0)相近。PEA技术简单、非放射性且血小板用量约为SRA的1/20,对HIT诊断具有高准确性。

要点

  • 在409例疑似HIT成人中,PEA诊断HIT的AUC为0.94(95%CI 0.87-1.0)。
  • SRA的AUC为0.91(95%CI 0.82-1.0),PEA与SRA诊断准确性相似。
  • 敏感性分析中PEA与SRA的AUC分别为0.88(95%CI 0.78-0.98)与0.86(95%CI 0.77-0.96)。

核心结论

  • PEA是一种技术简单、非放射性且血小板用量约为SRA的1/20的试验,对HIT诊断具有高准确性。
  • PEA的广泛应用可能有助于对疑似HIT患者进行及时和更有效的管理。

研究设计与样本

  • 前瞻性盲法研究,纳入409例连续成人疑似HIT患者。
  • 按预设标准(结合4Ts评分与HIT ELISA结果)将患者分为疾病阳性、阴性或不确定。
  • 主要分析中将HIT不确定者视为疾病阴性,敏感性分析中视为疾病阳性。
  • 采用受试者工作特征曲线统计比较PEA与SRA识别HIT患者的能力。

主要发现

  • 主要分析中PEA的AUC为0.94(95%CI 0.87-1.0),SRA的AUC为0.91(95%CI 0.82-1.0)。
  • 敏感性分析中PEA的AUC为0.88(95%CI 0.78-0.98),SRA的AUC为0.86(95%CI 0.77-0.96)。
  • PEA与SRA的诊断准确性相似。

关键数值与推荐

  • 预设标准结合4Ts评分与HIT ELISA结果对疑似HIT进行分类。
  • PEA主要分析AUC 0.94(95%CI 0.87-1.0),敏感性分析AUC 0.88(95%CI 0.78-0.98)。
  • SRA主要分析AUC 0.91(95%CI 0.82-1.0),敏感性分析AUC 0.86(95%CI 0.77-0.96)。
  • PEA使用血小板数量约为SRA的1/20。

临床怎么用

  • 原文结论认为PEA对HIT诊断具有高准确性。
  • 原文认为PEA的广泛应用可能有助于对疑似HIT患者进行及时和更有效的管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is a life-threatening, prothrombotic, antibody-mediated disorder. To maximize the likelihood of recovery, early and accurate diagnosis is critical. Widely available HIT assays, such as the platelet factor 4 (PF4) heparin enzyme-linked immunosorbent assay (ELISA) lack specificity, and the gold-standard carbon 14-labeled serotonin release assay (SRA) is of limited value for early patient management because it is available only through reference laboratories. Recent studies have demonstrated that pathogenic HIT antibodies selectively activate PF4-treated platelets and that a technically simpler assay, the PF4-dependent P-selectin expression assay (PEA), may provide an option for rapid and conclusive results. Based upon predefined criteria that combined 4Ts scores and HIT ELISA results, 409 consecutive adults suspected of having HIT were classified as disease positive, negative, or indeterminate. Patients deemed HIT indeterminate were considered disease negative in the primary analysis and disease positive in a sensitivity analysis. The ability of PEA and SRA to identify patients judged to have HIT was compared using receiver operating characteristic curve statistics. Using these predefined criteria, the diagnostic accuracy of PEA was high (area under the curve [AUC], 0.94; 95% confidence interval [CI], 0.87-1.0) and similar to that of SRA (AUC, 0.91; 95% CI, 0.82-1.0). In sensitivity analysis, the AUCs of PEA and SRA were also similar at 0.88 (95% CI, 0.78-0.98) and 0.86 (95% CI, 0.77-0.96), respectively. The PEA, a technically simple nonradioactive assay that uses ∼20-fold fewer platelets compared with the SRA, had high accuracy for diagnosing HIT. Widespread use of the PEA may facilitate timely and more effective management of patients with suspected HIT.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Samuelson Bannow B, Warad DM, Jones CG, et al. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis. Blood. 2021. PMID: 32898858. doi:10.1182/blood.2020008195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。